1162408005: Benzoxonium chloride (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Benzoxonium chloride

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Quaternary ammonium compound\Benzoxonium chloride

\Organic compound\Organic nitrogen compound\Quaternary ammonium compound\Benzoxonium chloride

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4589223014 Bradophen en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4589226018 Benzoxonium chloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4589227010 Benzoxonium chloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Benzoxonium chloride	Is a	Quaternary ammonium compound	true	Inferred relationship	Some
Benzoxonium chloride	Is a	Anti-infective agent (substance)	true	Inferred relationship	Some
Benzoxonium chloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Benzoxonium	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely benzoxonium chloride 1 milligram and lidocaine hydrochloride 1 milligram/1 each conventional release chewable tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Benzoxonium chloride	Inferred relationship	Some	1
Product containing precisely benzoxonium chloride 1 milligram and lidocaine hydrochloride 1 milligram/1 each conventional release chewable tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Benzoxonium chloride	Inferred relationship	Some	1

This concept is not in any reference sets